Frontiers | Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?
Design of Negative and Positive Allosteric Modulators of the Cannabinoid CB2 Receptor Derived from the Natural Product Cannabidiol | Journal of Medicinal Chemistry
Structure of an allosteric modulator bound to the CB1 cannabinoid receptor | Nature Chemical Biology
Allosteric inhibition explained through conformational ensembles sampling distinct “mixed” states - ScienceDirect
Allosteric inhibition explained through conformational ensembles sampling distinct “mixed” states - ScienceDirect
Diversity of molecular targets and signaling pathways for CBD - Almeida - 2020 - Pharmacology Research & Perspectives - Wiley Online Library
IJMS | Free Full-Text | Possible Receptor Mechanisms Underlying Cannabidiol Effects on Addictive-like Behaviors in Experimental Animals
Can CBD Negate your THC High? | Cannabis Sciences
Cannabidiol binding and negative allosteric modulation at the cannabinoid type 1 receptor in the presence of delta-9-tetrahydrocannabinol: An In Silico study | PLOS ONE
New AKT-dependent mechanisms of anti-COVID-19 action of high-CBD Cannabis sativa extracts | Cell Death Discovery
THC vs. CBD: Which Is Right for You? | Ozark MMJ Cards
Inhibition by allosteric partial agonists through perturbation of... | Download Scientific Diagram
Molecules | Free Full-Text | Allosteric Modulation of the CB1 Cannabinoid Receptor by Cannabidiol—A Molecular Modeling Study of the N-Terminal Domain and the Allosteric-Orthosteric Coupling
Schematic presentation of the effect of different GPCR allosteric... | Download Scientific Diagram
What's the Difference Between THC and CBD? Medical Marijuana THC
Cannabidiol binding and negative allosteric modulation at the cannabinoid type 1 receptor in the presence of delta-9-tetrahydrocannabinol: An In Silico study | PLOS ONE
Frontiers | Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson's Disease
Frontiers | Quality of Life and a Surveillant Endocannabinoid System
Cannabidiol binding and negative allosteric modulation at the cannabinoid type 1 receptor in the presence of delta-9-tetrahydrocannabinol: An In Silico study | PLOS ONE
CBD: A New Hope? | ACS Medicinal Chemistry Letters
Allosteric Modulation of the CB1 Cannabinoid Receptor by Cannabidiol—A Molecular Modeling Study of the N-Terminal Domain and t
Cannabinoids and COVID-19 with Richard van Breemen
Allosteric pluripotency as revealed by protein kinase A | Science Advances
